What Causes Waldenström's Macroglobulinemia: Genetic or Immune-Related Factors, or a Combination?
- 1 February 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 85-87
- https://doi.org/10.3816/clml.2011.n.015
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregationBlood, 2010
- Immune-Related and Inflammatory Conditions and Risk of Lymphoplasmacytic Lymphoma or Waldenstrom MacroglobulinemiaJNCI Journal of the National Cancer Institute, 2010
- Autoimmunity and lymphomagenesisInternational Journal of Cancer, 2009
- Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia patients: a population-based study in SwedenBlood, 2008
- Chronic Immune Stimulation and Subsequent Waldenström MacroglobulinemiaJAMA Internal Medicine, 2008
- The use of TNF-α blocking agents in rheumatoid arthritis: an updateExpert Opinion on Pharmacotherapy, 2007
- Genomewide Linkage Screen for Waldenström Macroglobulinemia Susceptibility Loci in High-Risk FamiliesAmerican Journal of Human Genetics, 2006
- Familial Aggregation and Heterogeneity of Non-Hodgkin Lymphoma in Population-Based SamplesCancer Epidemiology, Biomarkers & Prevention, 2005
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Waldenström's macroglobulinemia*Cancer, 1998